Ishita Drugs and Industries Q3FY22 net profit at Rs. 15.49 lakhs

ISHITA DRUGS & INDUSTRIES LTD. has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 4.3434 crores during the period ended December 31, 2021 as compared to Rs. 2.9464 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.1549 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.1392 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.52 for the period ended December 31, 2021 as compared to Rs. 0.47 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 4.3434 crs	₹2.9464 crs	47.41%
Net Profit	₹0.1549 crs	₹0.1392 crs	11.28%
EPS	₹0.52	₹0.47	10.64%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 4.3434 crores during the period ended December 31, 2021 as compared to Rs.3.8401 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.1549 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.1372 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.52 for the period ended December 31, 2021 as compared to Rs.0.46 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 4.3434 crs	₹3.8401 crs	13.11%
Net Profit	₹0.1549 crs	₹0.1372 crs	12.90%
EPS	₹0.52	₹0.46	13.04%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.10.2170 crores during the 9 Months period ended December 31, 2021 as compared to Rs.9.9810 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.4302 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.3792 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.1.44 for the 9 Months period ended December 31, 2021 as compared to Rs.1.27 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹10.2170 crs	₹9.9810 crs	2.36%
Net Profit	₹0.4302 crs	₹0.3792 crs	13.45%
EPS	₹1.44	₹1.27	13.39%

Shares of ISHITA DRUGS & INDUSTRIES LTD. was last trading in BSE at Rs. 38.90 as compared to the previous close of Rs. 39.95. The total number of shares traded during the day was 1045 in over 27 trades.

The stock hit an intraday high of Rs. 42.00 and intraday low of 37.80. The net turnover during the day was Rs. 40945.00.

Source : Equity Bulls

Keywords

IshitaDrugsandIndustries Q3FY22 9MFY22 ResultUpdate